Stock Information
Abcellera Biologics Inc (ABCL)
Ticker Symbol: ABCL
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $1,731.05 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.5447
Revenue (TTM): $0.22 M
Dividend Yield: N/A%
ROE: -17.49%
Latest News
-
What's Going on With AbCellera Biologics Stock On Wednesday?
Wed, Aug 12, 2026 1:54 PM
-
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Wed, Aug 12, 2026 8:06 AM
-
AbCellera: Excellent Phase 2 Data In Menopause But The Platform Narrative Is Fading
Tue, Aug 11, 2026 4:55 PM
-
AbCellera Biologics Commences Underwritten Public Offering Of $200M Of Its Common Shares
Tue, Aug 11, 2026 4:03 PM
-
Truist Securities Maintains Buy on AbCellera Biologics, Raises Price Target to $30
Tue, Aug 11, 2026 1:30 PM
-
Here are the top movers in Monday's session.
Mon, Aug 10, 2026 7:00 PM
-
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes Transcript
Mon, Aug 10, 2026 4:38 PM
-
There are notable gap-ups and gap-downs in today's session.
Mon, Aug 10, 2026 2:30 PM
-
AbCellera Biologics Menopause Drug Data Shows 'New Efficacy Benchmark'
Mon, Aug 10, 2026 2:12 PM
-
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes - Slideshow
Mon, Aug 10, 2026 1:19 PM
Key Financials
Financial data not available